FLT1 and neoplasm: Compounds 3 and 4 significantly inhibited the invasion of HCT-116 cells and notably suppressed the expression of VEGFR-1 and vimentin (a biomarker of EMT), suggesting that they may inhibit tumor cell metastasis by preventing the EMT process through downregulation of VEGFR-1 expression.